Redmile Group, LLC 13F Holdings

Holdings from the most recent 13F from Redmile Group, LLC

Filed: 2018-08-14 (Q2 2018) | Holdings: 81 | Value: $2.9B | Filing Link

PREMIUM

Author Returns

Returns are calculated from when the filing is published and are weighted by the size of the holding.

Filing Returns

Returns are calculated from when the filing is published and are weighted by the size of the holding.

Holding Returns
StockPut/Call
Change
Holding Pct
Value
Current Return
3M Return
1Y Return
ARRY1 - ARRAY BIOPHARMA INC
New Purchase
9.11%
$268.1M
FOLD - AMICUS THERAPEUTICS INC
New Purchase
5.58%
$164.2M
-58.45%
-24.58%
-27.56%
ATRA - ATARA BIOTHERAPEUTICS INC
New Purchase
5.15%
$151.7M
-99.16%
-6.52%
-65.19%
IMGN - IMMUNOGEN INC
New Purchase
4.07%
$119.8M
-36.49%
-70.04%
XNCR - XENCOR INC
New Purchase
3.96%
$116.5M
-79.56%
-4.74%
-1.39%
RGNX - REGENXBIO INC
New Purchase
3.81%
$112.0M
-86.93%
-4.84%
-45.80%
ALDR - ALDER BIOPHARMACEUTICALS INC
New Purchase
3.49%
$102.8M
-31.40%
-51.19%
WCG - WELLCARE HEALTH PLANS INC
New Purchase
2.97%
$87.4M
-14.70%
-6.64%
WVE - WAVE LIFE SCIENCES LTD
New Purchase
2.92%
$85.9M
-85.05%
-15.80%
-55.93%
BOLD - AUDENTES THERAPEUTICS INC
New Purchase
2.89%
$85.2M
CLVS - CLOVIS ONCOLOGY INC
New Purchase
2.72%
$80.0M
FATE - FATE THERAPEUTICS INC
New Purchase
2.56%
$75.5M
-89.30%
+11.32%
+55.53%
IFRX - INFLARX NV
New Purchase
2.22%
$65.4M
-97.51%
-12.96%
-92.00%
CNC - CENTENE CORP DEL
New Purchase
2.13%
$62.6M
-22.87%
-4.99%
-33.48%
QURE - UNIQURE NV
New Purchase
2.09%
$61.4M
-58.29%
-14.56%
+54.75%
ALXN - ALEXION PHARMACEUTICALS INC
New Purchase
2.06%
$60.7M
+0.66%
-8.29%
LIVN - LIVANOVA PLC
New Purchase
2.03%
$59.9M
-63.30%
-0.14%
-37.02%
DCPH - DECIPHERA PHARMACEUTICALS IN
New Purchase
1.97%
$58.1M
-34.10%
+5.25%
ARGX - ARGENX SE
New Purchase
1.90%
$55.8M
+520.37%
+5.90%
+55.39%
ICUI - ICU MED INC
New Purchase
1.84%
$54.1M
-56.12%
-16.75%
-43.01%
LH - LABORATORY CORP AMER HLDGS
New Purchase
1.76%
$51.8M
+76.33%
-8.56%
-8.94%
INSM - INSMED INC
New Purchase
1.63%
$48.1M
+374.30%
-19.69%
-26.13%
SYNH - SYNEOS HEALTH INC
New Purchase
1.56%
$46.0M
+2.69%
+3.18%
XERS - XERIS PHARMACEUTICALS INC
New Purchase
1.56%
$45.8M
BLUE - BLUEBIRD BIO INC
New Purchase
1.43%
$42.1M
-21.07%
-24.79%
CBAY - CYMABAY THERAPEUTICS INC
New Purchase
1.35%
$39.7M
-23.26%
-52.43%
MPSY.F - MORPHOSYS AG
New Purchase
1.31%
$38.5M
-0.14%
+7.32%
ANAB - ANAPTYSBIO INC
New Purchase
1.25%
$36.9M
-71.04%
-20.15%
-38.10%
HSKA - HESKA CORP
New Purchase
1.25%
$36.8M
+1.45%
-26.64%
UNH - UNITEDHEALTH GROUP INC
New Purchase
1.19%
$35.1M
+30.65%
+1.47%
-5.38%
ELV - ANTHEM INC
New Purchase
1.18%
$34.8M
+55.46%
+7.96%
+4.99%
GLYC - GLYCOMIMETICS INC
New Purchase
1.11%
$32.7M
-98.94%
-21.77%
-79.50%
IRTC - IRHYTHM TECHNOLOGIES INC
New Purchase
1.11%
$32.6M
+73.44%
-12.88%
-13.47%
EHTH - EHEALTH INC
New Purchase
1.03%
$30.5M
-85.53%
+20.01%
+271.06%
OXFD - OXFORD IMMUNOTEC GLOBAL PLC
New Purchase
0.98%
$28.8M
+4.50%
-3.95%
NITE - NIGHTSTAR THERAPEUTICS PLC
New Purchase
0.97%
$28.6M
CTLT - CATALENT INC
New Purchase
0.94%
$27.7M
-3.05%
+37.21%
ABT - ABBOTT LABS
New Purchase
0.93%
$27.4M
+134.73%
+11.93%
+34.50%
EPZM - EPIZYME INC
New Purchase
0.93%
$27.4M
-25.27%
+27.66%
SRRK - SCHOLAR ROCK HLDG CORP
New Purchase
0.93%
$27.3M
+162.81%
+50.36%
-24.75%
N/A - ALDER BIOPHARMACEUTICALS INC
New Purchase
0.89%
$26.1M
N/A - ARRAY BIOPHARMA INC
New Purchase
0.87%
$25.5M
ELGXQ - ENDOLOGIX INC
New Purchase
0.83%
$24.5M
-59.51%
-75.26%
TFX - TELEFLEX INC
New Purchase
0.73%
$21.4M
-46.99%
+13.39%
+60.81%
ZTS - ZOETIS INC
New Purchase
0.72%
$21.2M
+79.27%
+0.60%
+36.68%
CMRX - CHIMERIX INC
New Purchase
0.58%
$17.1M
-19.05%
-39.52%
SYRS - SYROS PHARMACEUTICALS INC
New Purchase
0.57%
$16.7M
-99.98%
-30.70%
-13.60%
TCDA - TRICIDA INC
New Purchase
0.51%
$14.9M
+28.72%
+38.89%
ODTC - ODONATE THERAPEUTICS INC
New Purchase
0.46%
$13.5M
-13.35%
+75.40%
TDOC - TELADOC INC
New Purchase
0.46%
$13.4M
-90.11%
-14.90%
-19.63%